top of page

News & Updates

Filter by:

Lucence secures US Medicare approval for its cancer tests

News & Updates

Mar 20, 2023

Lucence secures US Medicare approval for its cancer tests

Read More
Lucence secures US Medicare approval for its cancer tests
Lucence Announces Medicare Reimbursement Decision for LiquidHALLMARK® Assay in Lung Cancer

News & Updates

Feb 22, 2023

Lucence Announces Medicare Reimbursement Decision for LiquidHALLMARK® Assay in Lung Cancer

Read More
Lucence Announces Medicare Reimbursement Decision for LiquidHALLMARK® Assay in Lung Cancer
Lucence Shares Promising Interim Data from LIQUIK Prospective Study at ISLB 2022

News & Updates

Oct 23, 2022

Lucence Shares Promising Interim Data from LIQUIK Prospective Study at ISLB 2022

Read More
Lucence Shares Promising Interim Data from LIQUIK Prospective Study at ISLB 2022
Lucence and Omnigen Partner to bring Amplicon-based Liquid Biopsy Tests to Turkey

News & Updates

Oct 18, 2022

Lucence and Omnigen Partner to bring Amplicon-based Liquid Biopsy Tests to Turkey

Read More
Lucence and Omnigen Partner to bring Amplicon-based Liquid Biopsy Tests to Turkey
Lucence Collaborates with National Cancer Centre Singapore to Launch Prospective Liquid Biopsy Study for Prostate Cancer

News & Updates

Sep 26, 2022

Lucence Collaborates with National Cancer Centre Singapore to Launch Prospective Liquid Biopsy Study for Prostate Cancer

Read More
Lucence Collaborates with National Cancer Centre Singapore to Launch Prospective Liquid Biopsy Study for Prostate Cancer
Local Study Demonstrates Synergies of Using Blood-based Liquid Biopsies to complement Tissue Biopsies for Lung Cancer Diagnosis

News & Updates

Jul 28, 2022

Local Study Demonstrates Synergies of Using Blood-based Liquid Biopsies to complement Tissue Biopsies for Lung Cancer Diagnosis

Read More
Local Study Demonstrates Synergies of Using Blood-based Liquid Biopsies to complement Tissue Biopsies for Lung Cancer Diagnosis
Lucence Presents Data at 2022 World Conference on Lung Cancer (WCLC) Supporting Utility of Amplicon-Based Liquid Biopsy

News & Updates

Jul 14, 2022

Lucence Presents Data at 2022 World Conference on Lung Cancer (WCLC) Supporting Utility of Amplicon-Based Liquid Biopsy

Read More
Lucence Presents Data at 2022 World Conference on Lung Cancer (WCLC) Supporting Utility of Amplicon-Based Liquid Biopsy
Lucence Showcases Promising Data on ctDNA and ctRNA Liquid Biopsy Assay for Lung Cancer at 2022 ASCO Annual Meeting

News & Updates

May 31, 2022

Lucence Showcases Promising Data on ctDNA and ctRNA Liquid Biopsy Assay for Lung Cancer at 2022 ASCO Annual Meeting

Read More
Lucence Showcases Promising Data on ctDNA and ctRNA Liquid Biopsy Assay for Lung Cancer at 2022 ASCO Annual Meeting
Lucence Announces Publication of Validation Study for LiquidHALLMARK ctDNA Liquid Biopsy Assay

News & Updates

May 19, 2022

Lucence Announces Publication of Validation Study for LiquidHALLMARK ctDNA Liquid Biopsy Assay

Read More
Lucence Announces Publication of Validation Study for LiquidHALLMARK ctDNA Liquid Biopsy Assay

1

/

5

bottom of page